Raphael Pharmaceutical Valuation
| RAPH Stock | 0.26 0.00 0.00% |
Raphael Pharmaceutical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Raphael Pharmaceutical from analyzing the company fundamentals such as Net Income of (1.62 B), total asset of 422 K, and Return On Asset of -19.04 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support purchasing undervalued entities and trading away overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Raphael Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of Raphael Pharmaceutical is based on 3 months time horizon. Increasing Raphael Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Raphael otc stock is determined by what a typical buyer is willing to pay for full or partial control of Raphael Pharmaceutical. Since Raphael Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Raphael OTC Stock. However, Raphael Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.26 | Real 0.25 | Hype 0.26 |
The intrinsic value of Raphael Pharmaceutical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Raphael Pharmaceutical's stock price.
Estimating the potential upside or downside of Raphael Pharmaceutical helps investors to forecast how Raphael otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Raphael Pharmaceutical more accurately as focusing exclusively on Raphael Pharmaceutical's fundamentals will not take into account other important factors: Raphael Pharmaceutical Total Value Analysis
Raphael Pharmaceutical is at this time projected to have valuation of 0 with market capitalization of 17.19 M, debt of , and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Raphael Pharmaceutical fundamentals before making equity appraisal based on enterprise value of the companyRaphael Pharmaceutical Asset Utilization
One of the ways to look at asset utilization of Raphael is to check how much profit was generated for every dollar of assets it reports. Raphael Pharmaceutical holds a negative application of assets of -19.04 pct., losing USD0.19 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Raphael Pharmaceutical shows how discouraging it operates for each dollar spent on its assets.Raphael Pharmaceutical Profitability Analysis
Net Loss for the year was (1.62 B) with profit before overhead, payroll, taxes, and interest of 0.About Raphael Pharmaceutical Valuation
An absolute valuation paradigm, as applied to Raphael OTC Stock, attempts to find the value of Raphael Pharmaceutical based on its fundamental and basic technical indicators. By analyzing Raphael Pharmaceutical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Raphael Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Raphael Pharmaceutical. We calculate exposure to Raphael Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Raphael Pharmaceutical's related companies.8 Steps to conduct Raphael Pharmaceutical's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Raphael Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Raphael Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Raphael Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Raphael Pharmaceutical's revenue streams: Identify Raphael Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Raphael Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Raphael Pharmaceutical's growth potential: Evaluate Raphael Pharmaceutical's management, business model, and growth potential.
- Determine Raphael Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Raphael Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Raphael Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 15.5 M | |
| Retained Earnings | -2.7 M |
Complementary Tools for Raphael OTC Stock analysis
When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |